|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 17 of 30 found articles
| Title: |
Is BTKi or BCL2i preferable as first novel therapy in patients with CLL? The case for BCL2i |
| Author: |
Seymour, John F. |
| Appeared in: |
Blood advances |
| Paging: | Volume 6 () nr. 4 pages 1365-1370 |
| Year: |
2022 |
| Contents: | |
| Publisher: |
The American Society of Hematology |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 17 of 30 found articles
| << previous | next >> |